The Prognostic Value of Serum Procalcitonin Monitoring in Febrile Neutropenic Patients with Hematological Malignancies
Caroline Maged Abd Elmessih Hezkial;
Abstract
Patients with hematological malignancies are immuno-compromised as a result of the underlying malignancy or due to the therapeutic interventions employed to manage it (Sharma and Lokeshwar, 2005).
Febrile neutropenia resulting from cytotoxic chemotherapy
Febrile neutropenia resulting from cytotoxic chemotherapy
Other data
| Title | The Prognostic Value of Serum Procalcitonin Monitoring in Febrile Neutropenic Patients with Hematological Malignancies | Other Titles | القيمة التنبؤية لتتبع مستوى ال بروكالسيتونين في مرضى قلة العدلات الحموية الناتجة من امراض الدم الخبيثة | Authors | Caroline Maged Abd Elmessih Hezkial | Keywords | The Prognostic Value of Serum Procalcitonin Monitoring in Febrile Neutropenic Patients with Hematological Malignancies | Issue Date | 2014 | Description | Patients with hematological malignancies are immuno-compromised as a result of the underlying malignancy or due to the therapeutic interventions employed to manage it (Sharma and Lokeshwar, 2005). Febrile neutropenia resulting from cytotoxic chemotherapy |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 124919G3736.pdf | 464.24 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.